Curcumin's Potential as a Therapeutic Agent for Hpv-Induced Cancer
DOI:
https://doi.org/10.63142/ijeti.v1i1.242Keywords:
Anti-inflammatory, Apoptosis, Cervical Cancer, Curcumin, Human PapillomavirusAbstract
Curcumin, the main active compound of turmeric (Curcuma longa), shows potential as a therapeutic agent for Human Papillomavirus (HPV)-induced cancer. This study examines the mechanism of action of curcumin in inhibiting the proliferation of HPV-infected cervical cancer cells, including its anti-inflammatory, anti-cancer, and anti-viral properties reviewed from several references. Curcumin works by suppressing the expression of E6 and E7 oncoproteins, induction of apoptosis, and modulation of signaling pathways that support tumor growth, such as NF-κB. Although curcumin has great potential, the challenges of low bioavailability and rapid metabolism in the body still need to be overcome. Further research is needed to optimize the formulation and delivery method of curcumin as a cancer therapy.
References
Nanang, S. B. (2018). Mengenal Human Papiloma Virus Sebagai Faktor Resiko Kanker Serviks. Well being, vol. 3, no. 1, pp. 49-51.
Idrees, K. K. M., Zahra, A., & Faridi, R. (2011). Oncogenic potential of Human Papillomavirus (HPV) and its relation with cervical cancer. Virology Journal, 8:269.
Stanley, M. (2013). Genital human papillomavirus infection-current and prospective therapies. J Natl Cancer Inst Monogr, vol. 31, pp. 117-2.
Viol, K. D. (2019). Human Papillomavirus (HPV) Patologi dan Biologi Molekuler. Generasi Biologi. Generasi Biologi Indonesia.
Hildeshein, A., Herrero, R., Schiffman, M., Quint, W., Bougelet, C., Doorn, V. J. L., Solomon, D., Wacholder, S., Sherman, M., Jimenez, S., Hutchinson, M., Gonzaález, P., Rodriguez, A., Coseo, S., Safaeian, M., Bennett, C., & Porass, C. (2010). Faktor Penentu Seropositifitas Di Antara Muda Positif HPV16/18DNA. BMC Infect Dis, 10: 238.
Suhrbier, A., Birell, G., Gardner, J., Major, L., Lambley, E., Antalis, T. M., Schroder, W. A., & Darnell, G. A. (2007). Virus papiloma manusia E, membutuhkan protease calpain untuk mendegradasi protein retinoblastoma. J Biol Chem, 282: 37492-37500.
Saeed, K., Nadeem, N. J., Khan, M. N., Rai, M. A., Majid, S., Adnan, A., Shahid, P., Nusrat, K., Aliya, A., & Syed, A. H. (2007). Human papillomavirus subtype 16 is common in Pakistani women with cervical carcinoma. International Journal of Infectious Diseases, vol. 11, no. 4, pp. 313-317.
Jacqueline, H. (2018). Disparities in HPV vaccination rates and HPV prevalence in the United States. Hum Vaccin Immunother, vol. 15, no. 1, pp. 146-155.
Alok, M., Bhudev, D., C. (2015). Curcumin As An Anti-Human Papillomavirus And Anti- Cancer Compound. Future Oncology, vol. 11, no. 18, pp. 2487-90.
Chandrasekhar, D., S., Radhakrishna, P., M. (2006). Antitumor Action Of Curcumin In Human Papillomavirus Associated Cells Involves Downregulation Of Viral Oncogenes, Prevention Of Nfkb And AP-1 Translocation, And Modulation Of Apoptosis. Molecular Carcinogenesis, vol. 45, no. 5, pp. 320-32.
Xingyu, Z., Ruowen, Z., Zitong, S., Kun, Y., Han, H., Lianhai, J., Wei, Z. (2024). Curcumin Suppressed The Proliferation And Apoptosis Of HPV-Positive Cervical Cancer Cells By Directly Targeting The E6 Protein. Phytotherapy research, vol. 38, no. 10, pp. 4967-4981.
Parks, R., Jennings, M. (2020). Antiviral Effects Of Curcumin On Adenovirus Replication. Microorganisms, vol. 8, no. 10, pp.1–16.
Oh JK, Weslmpass E. (2022). Infection and cancer mal dirination and burden of diseases Ann Gleb Hoakh 80, 384-397.
Hausen H. zur (2020). Papillomaviruses in the causation of human a brief historical ассолии. Убоду 384, 260-265.
Gaman L., zur Hausen H. (2023). Partial characterization of viral DNA from human genital warts (condylomata acuminate). Ir. Cancer 25, 503-609.
Das BC, Husain S. Nasare V. Bharadwaj M. (2019). Prospects and prejudices of human papillomavirus vaccines in India. Veerтие 26, 2669-2679.
Hetero R. Gonciles P, Markowitz LE (2024). Present status of human papillomavirus vaccine development and implementation. Lancet Oncul. 2045, 70481-70481.
Villa LL. Costa RL. Fettac A er al (2022). Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) LI virus-like partide vaccine e in young womens a randomized double-blind placebo-controlled multicentre Phase II efficacy trial. Lancet Oncol. 6, 271–278.
Harver DM, Franco EL, Wheeler C et al. (2020). Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomized controlled trial. Lancet 364, 1757–1765.
Tuttle S, Hertan L, Daurio N et al. (2022). The chemopreventive and clinically used agent curcumin sensitizes HPV (-) but not HPV (+) HNSCC to ionizing radiation, in vitro and in a mouse orthotropic model. Cancer Biol. Ther. 13, 575–584.
Pils S, Joura EA. (2020). From the monovalent to the nine-valent HPV vaccine. Clin. Microbiol. Infect. doi: 10.1016/j.cmi.2015.05.001.
Zur Hausen H. (2022). Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2, 342–350.
Rosl F, Das BC, Lengert M, Geletneky K, zur Hausen H. (2018). Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription. J. Virol. 71, 362–370.
Aggarwal, B., B., Kumar, A., & Bharti, A., C. (2003). Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Research, vol. 23, no. 1B), pp. 363-398.
Sharma RA, Euden SA, Platton SL et al. (2024). Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin. Cancer Res. 10, 6847–6854.
Prasad S, Tyagi AK, Aggarwal BB. (2020). Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Res. Treat. 46, 2–18.
Dorai, T. (2000). Therapeutic potential of curcumin in human prostate cancer. II. Curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein. Molecular Urology, vol. 4, no. 1, pp. 1-6.
Kumar S, Jena L, Galande S, Daf S, Mohod K, Varma AK. (2021). Elucidating molecular interactions of natural inhibitors with HPV-16 E6 oncoprotein through docking analysis. Genomics Inform. 12, 654–670.
Han, S., S., Keum, Y., S., Seo, H., J., & Surh, Y., J. (2002). Curcumin suppresses activation of NF-κB, and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. Journal of Biochemistry and Molecular Biology, vol. 35, no. 4, pp. 337-342.
Aggarwal, B., B., Kumar, A., & Bharti, A., C. (2003). Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Research, vol. 23, no. 1B), pp. 363-398.
Han, S., S., Keum, Y., S., Seo, H., J., & Surh, Y., J. (2002). Curcumin suppresses activation of NF-κB, and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. Journal of Biochemistry and Molecular Biology, vol. 35, no. 4, pp. 337-342.
Dang YP, Yuan XY, Tian R, Li DG, Liu W. (2021). Curcumin improves the paclitaxel-induced apoptosis of HPV-positive human cervical cancer cells via the NF-κB-p53-caspase-3 pathway. Ther. Med. 9, 1470–1476.
Chakraborty S, Das K, Saha S et al. (2024). Nuclear matrix protein SMAR1 represses c- Fosmediated HPV18 E6 transcription through alteration of chromatin histone deacetylation. J. Biol. Chem. 42, 29074–29085.
Prusty BK, Das BC. (2024). Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin. Int. J. Cancer 113, 951–960.
Mishra A, Kumar R, Kohaar I et al. (2019). Curcumin modulates cellular AP-1, NF-kB, and HPV16 E6 proteins in oral cancer. Ecancermedicalscience 9, 525.
Basu P, Dutta S, Begum R et al. (2023). Clearance of cervical human papillomavirus infection by topical application of curcumin and curcumin containing polyherbal cream: a Phase II randomized controlled study. Asian Pac. J. Cancer Prev. 14, 5753–5759.
Mudduluru G, George-William JN, Muppala S. (2021). Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. Biosci. Rep. 31, 185–197.
Debata PR, Castellanos MR, Fata JE et al. (2023). A novel curcumin-based vaginal cream Vacurin selectively eliminates apposed human cervical cancer cells. Gynecol. Oncol. 129, 145–153.
Maher DM, Bell MC, O’Donnell EA, Gupta BK, Jaggi M, Chauhan SC. (2021). Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo [a] pyreneinduced up regulation of HPV E7. Mol. Carcinog. 50, 47–57.
Talwar GP, Dar SA, Rai MK et al. (2020). A novel polyhedral microbicide with inhibitory effect on bacterial, fungal and viral genital pathogens. Int. J. Antimicrob. Agents 32, 180–185.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Triani Nur Fitri, Adilla Syahsiyatun Najah, Syifa Salsabila Mulyani, Wulan Pertiwi (Author)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
How to Cite
